A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors
Clinical trial NCT02243917 · TERMINATED
Trial details
- NCT number
- NCT02243917
- Sponsor
- Cleave Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-11
- Primary completion
- 2017-08-25
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.